Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / The European In Vitro Diagnostic Regulation: Performance Evaluation

The European In Vitro Diagnostic Regulation: Performance Evaluation

Facebook0
Google+0
LinkedIn0
Twitter0
By Erica Kramer, Ph.D., Senior Nerac Analyst/Medical Writer
Originally Published: June 30, 2020

In May 2017, the European Parliament and Council published Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), repealing Directive 98/79/EC (IVDD). The new regulation will apply starting May 26, 2022.

Unlike under the IVDD, which allowed for self-certification for many devices and manufacturers, the IVDR will require a majority of manufacturers to obtain notified body certifications. Since there are no “grandfathering” provisions in the IVDR, this will apply even to devices that have an extensive history on the European market. The increased burden associated with the IVDR requirements, notably the increased emphasis on clinical evidence and performance, will require many manufacturers to assess their portfolio to determine which products will transition to IVDR and to prioritize technical file updates.

This article explores clinical evidence, performance evaluation and the resulting challenges to manufacturers, and offers guidance on how to navigate them with success. Read more here!

The article is free!

Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
Please wait...
Loader

Related Posts

  • The European In Vitro Diagnostic Regulation: It’s Time to Start Preparing
    57
    By Erica Kramer, Ph.D., Nerac Analyst Originally Published: November 14, 2017 The global in vitro diagnostics (IVD) market was worth about $61.1 billion in 2016 and is projected to grow to $84.6 billion by 2023, with Europe accounting for the second largest market share after North America. The expected market growth, and increased interest in…
    Tags: diagnostic, vitro, eu, explores, article, manufacturers, read, published, regulation, erica
  • Preparing for a Notified Body Audit
    56
    By Ron Sills, M.S., Nerac Analyst, Originally Published: October 3rd, 2014 Is your company ready for an audit by your notified body?  Medical device manufacturers who market devices in Europe (or plan to) must undergo a rigorous certification process through a notified body, who are authorized on behalf of the European Union to ensure that…
    Tags: notified, body, devices, technical, requirements, certification, manufacturers, medical, compliance
  • Full Speed Ahead: Navigating the New European Medical Device Regulation
    55
    By Robert Zott, Director of Advisory Services Originally Published: July 18, 2018 The publication of the new Medical Device Regulation (MDR) 2017/745 in the European Journal, with its entry into force on May 25, 2017, marks the end of an eight-year period of controversy, and the beginning of a three-year transition to the most sweeping…
    Tags: european, regulation, medical, published, transition, read, article, manufacturers, originally, devices
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2021 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.